Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
December 4, 2018
The article explores how augmented intelligence enhances the capabilities of artificial intelligence, using FDNA as a key example. FDNA’s Face2Gene platform combines human expertise with advanced AI technology to analyze facial features and identify genetic disorders. By leveraging a robust database and sophisticated algorithms, FDNA’s augmented intelligence system achieves greater accuracy and speed in diagnosing these conditions. The article emphasizes that the synergy between human insight and AI augments the intelligence in AI, leading to improved patient outcomes and more efficient medical practices.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…